Rare diseases

Results: 4095



#Item
111Figure 1: Process of the orphan drug and orphan medical device research and development promotion program  Application for designation as orphan drug or orphan medical device for rare diseases Approval of designation a

Figure 1: Process of the orphan drug and orphan medical device research and development promotion program Application for designation as orphan drug or orphan medical device for rare diseases Approval of designation a

Add to Reading List

Source URL: www.nibio.go.jp

- Date: 2014-03-06 20:52:23
    112QALY-based appraisals and Rare Diseases

    QALY-based appraisals and Rare Diseases

    Add to Reading List

    Source URL: www.echoutcome.eu

    - Date: 2013-02-07 05:52:13
      113E-Rare-3 JTC 2015: Call text  E-Rare-3 Call for Proposals 2015 for

      E-Rare-3 JTC 2015: Call text E-Rare-3 Call for Proposals 2015 for "Transnational Research Projects on Rare Diseases" Submission deadline for pre-proposals: February 18, 2015

      Add to Reading List

      Source URL: www.agence-nationale-recherche.fr

      Language: English - Date: 2014-12-15 04:44:39
        114Austrian National Action Plan for Rare Diseases - Executive Summary

        Austrian National Action Plan for Rare Diseases - Executive Summary

        Add to Reading List

        Source URL: bmg.gv.at

        Language: English
          115Aartsma-Rus et al. Orphanet Journal of Rare Diseases 2012, 7(Suppl 2):A20 http://www.ojrd.com/content/7/S2/A20 MEETING ABSTRACT  Open Access

          Aartsma-Rus et al. Orphanet Journal of Rare Diseases 2012, 7(Suppl 2):A20 http://www.ojrd.com/content/7/S2/A20 MEETING ABSTRACT Open Access

          Add to Reading List

          Source URL: www.ojrd.com

          Language: English
            116Dimension Therapeutics Raises $30M Financing Dimension Therapeutics, a gene therapy company focused on developing novel  rare diseases, today announced the closing of a $30

            Dimension Therapeutics Raises $30M Financing Dimension Therapeutics, a gene therapy company focused on developing novel rare diseases, today announced the closing of a $30

            Add to Reading List

            Source URL: www.bioportfolio.com

            Language: English
              117Press Release ---------------- ERYtech Pharma and Genzyme Corporation sign collaborative research agreement in rare diseases th

              Press Release ---------------- ERYtech Pharma and Genzyme Corporation sign collaborative research agreement in rare diseases th

              Add to Reading List

              Source URL: erytech.com

              Language: English - Date: 2014-07-24 05:45:34
                118Tambuyzer et al. Orphanet Journal of Rare Diseases 2014, 9(Suppl 1):O18 http://www.ojrd.com/content/9/S1/O18 ORAL PRESENTATION  Open Access

                Tambuyzer et al. Orphanet Journal of Rare Diseases 2014, 9(Suppl 1):O18 http://www.ojrd.com/content/9/S1/O18 ORAL PRESENTATION Open Access

                Add to Reading List

                Source URL: www.ojrd.com

                Language: English
                  119Galanello and Origa Orphanet Journal of Rare Diseases 2010, 5:11 http://www.ojrd.com/contentOpen Access  REVIEW

                  Galanello and Origa Orphanet Journal of Rare Diseases 2010, 5:11 http://www.ojrd.com/contentOpen Access REVIEW

                  Add to Reading List

                  Source URL: www.ojrd.com

                  Language: English
                    120How we learned to cope with molecular biology data Annalisa Barla molecular biology • a typical scenario is n<<d • number of samples cannot always be increased (rare diseases and expensive

                    How we learned to cope with molecular biology data Annalisa Barla molecular biology • a typical scenario is n<Add to Reading List

                    Source URL: wiki.icub.org

                    Language: English - Date: 2010-06-09 16:52:44